Trump’s NIH pick grilled on research funding cuts and vaccine views in Senate hearing
- Dr. Jay Bhattacharya stated he is committed to providing NIH scientists with necessary resources if confirmed as director, emphasizing the mission to research for a healthier America.
- Bhattacharya expressed openness to supporting more studies on vaccines and autism, despite extensive research showing no link.
- During the Senate hearing, Bhattacharya mentioned it is a tragedy for a child to die from a vaccine-preventable disease and opposed NIH vaccine mandates during the pandemic.
- He outlined five concrete goals for his potential tenure as NIH director at the hearing.
44 Articles
44 Articles
Bhattacharya Would Be a Breath of Fresh Air at NIH
Dr. Jay Bhattacharya spoke about how important freedom of speech is for science on Wednesday during his Senate confirmation hearing to head the National Institutes of Health (find his opening statement and the full hearing here).
Trump NIH appointee Bhattacharya defends president's research funding cuts
Lays out new vision for future President Donald Trump's pick to be the next Director of the National Institutes of Health (NIH), Dr. Jay Bhattacharya, spent much of his confirmation hearing Wednesday defending the president's decision to put a 15% cap on indirect research costs dispersed by the NIH. Bhattacharya, a physician, Stanford professor of medicine and senior fellow at the university's Institute for Economic Policy Research, would not ex…
Trump’s NIH Nominee Vows To Ensure Transparency, Accountability
By Jacob Adams, The Daily Signal | March 05, 2025 During his confirmation hearing Wednesday to be the next director of the National Institutes of Health, Dr. Jay Bhattacharya promised he would bring transparency and accountability to federal government-funded research. Appearing before the Senate Committee on Health, Education, Labor and Pensions, Bhattacharya decried the government research establishment for abusing its authority during the CO…
Coverage Details
Bias Distribution
- 48% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage